05
Pharmaceutical preparations for the treatment of autoimmune
diseases and conditions; pharmaceutical preparations for the
treatment of hemophilia; pharmaceutical preparations for the
treatment of cancer and tumors; pharmaceutical preparations
for the treatment of multiple sclerosis, atopic dermatitis,
anti-drug antibody formation and xenotransplantation;
pharmaceutical preparations for use in immunotherapy,
namely, regulatory t-cell therapy
40
Manufacturing services for pharmaceutical products (Terms
too vague in the opinion of the International Bureau – Rule
13 (2) (b) of the Regulations); providing technical
information in the field of pharmaceutical manufacturing;
custom manufacturing of pharmaceuticals
42
Medical and pharmaceutical research and development
services; scientific research and development services in
the medical field; providing medical and scientific
information in the medical field; providing medical and
scientific research information in the field of
pharmaceuticals and clinical trials; scientific research and
development services in the field of regulatory t-cell and
chimeric antigen receptor therapy; scientific research and
development services in the field of new cancer therapies;
medical and veterinary research services, namely, the
manipulation of cells within a laboratory or research
facility to enable the cells to be used for therapeutic
purposes; scientific research in human and animal gene
therapy; scientific research into vectors and preparations
for manipulating and adapting human and animal cells;
consultancy relating to all the aforesaid services
44
Providing medical information in the field of
pharmaceuticals, autoimmune diseases and conditions,
hemophilia, cancer, multiple sclerosis, atopic dermatitis,
anti-drug antibody formation and xenotransplantation;
providing a website featuring information in the medical
field and in the field of pharmaceuticals, autoimmune
diseases and conditions, hemophilia, cancer, multiple
sclerosis, atopic dermatitis, anti-drug antibody formation
and xenotransplantation (Terms too vague in the opinion of
the International Bureau – Rule 13 (2) (b) of the
Regulations); consulting in the field of pharmaceuticals,
autoimmune diseases and conditions, hemophilia, cancer,
multiple sclerosis, atopic dermatitis, anti-drug antibody
formation and xenotransplantation; medical services;
veterinary services; medical services in the extraction of
human and animal cells from patients; manipulation of human
and animal cells for therapeutic purposes; reinsertion of
cells into human and animal patients for medical purposes;
providing medical and therapy advice and consultancy in the
field of medical and veterinary therapies; providing cancer
therapy advice and consultancy; providing information
relating to diagnostic, prophylactic and therapeutic
properties of pharmaceuticals
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen